A 10 year follow up study of patients transplanted for autoimmune hepatitis: Histological recurrence precedes clinical and biochemical recurrence

Gut

Volumn 52, Issue 6, 2003, Pages 893-897

  Duclos Vallee J C ^a,b   Sebagh, M ^a   Rifai, K ^b   Johanet, C ^c   Ballot, E ^c   Guettier, C ^a   Karam, V ^b   Hurtova, M ^b   Feray, C ^b   Reynes, M ^a   Bismuth, H ^b   Samuel, D ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b Gustave Roussy   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LIVER ANTIGEN; STEROID; TACROLIMUS;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; BIOCHEMISTRY; CHILD; CLINICAL ARTICLE; CLINICAL MEDICINE; FEMALE; FOLLOW UP; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; STEROID THERAPY;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BIOPSY; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MIDDLE AGED; PROGNOSIS; RECURRENCE;

EID: 0037508842     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.6.893     Document Type: Article

References (16)

1. Neuberger J, Portmann B, Calne R, et al. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation 1984;37:363-5.
2. Wright HL, Bou-Abboud CF, Hassanein T, et al. Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation 1992;53:136-9.
3. Prados E, Cuervas-Mons V, De La Mata M, et al. Outcome of autoimmune hepatitis after liver transplantation. Transplantation 1998;12:1645-50.
4. Götz G, Neuhaus R, Bechstein WO, et al. Recurrence of autoimmune hepatitis after liver transplantation. Transpl Proc 1999;31:430-1.
5. Ratziu V, Samuel D, Sebagh M, et al. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 1999;30:131-41.
6. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
7. Martini E, Abuaf N, Cavalli F, et al. Antibody to liver cytosol (anti LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988;8:1662-6.
8. Roitt M, Doniach D. Immunofluorescent test for the detection of antibodies. In: WHO Booklet of Immunological Studies. Geneva: World Health Organization, 1972:1-12.
9. Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J Hepatol 2000;33:208-15.
10. Reich DJ, Fiel I, Guarrera JV, et al. Liver transplantation for autoimmune hepatitis. Hepatology 2000;32:693-700.
11. Gonzalez-Koch A, Czaja AJ, Carpenter HA, et al. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001;7:302-10.
12. Van Thiel DH, Wright H, Caroll P, et al. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995;90:771-6.
13. Hurtova M, Duclos-Vallée JC, Johanet C, et al. Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient. Liver Transpl 2001;7:556-8.
14. Milkiewicz P, Hübscher SG, Skiba G, et al. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999;68:253-6.
15. Hübscher SG. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome. Liver Transpl 2001;7:285-91.
16. Kanzler S, Weidemann C, Gerken G, et al. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol 1999;31:635-40.